Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: DEXORGEN INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-07-13 to 2023-07-12
Current total value of award: $14625
Description: PSEUDOPARTICLES FOR SARS-COV-2 ENTRY INHIBITION ASSAY